approval
saveITOVEBI (INAVOLISIB) — FDA approval
community read0 votes
Sponsor: GENENTECH INC. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 6
- approval(atezolizumab + hyaluronidase (human recombinant)): TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalOct 2, 2025
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalOct 2, 2025
- approvalobinutuzumab: GAZYVA (OBINUTUZUMAB) — FDA approvalOct 17, 2025
- approvalobinutuzumab: GAZYVA (OBINUTUZUMAB) — FDA approvalOct 17, 2025
- approvalglofitamab: COLUMVI (GLOFITAMAB-GXBM) — FDA approvalOct 27, 2025
- approval(atezolizumab + hyaluronidase (human recombinant)): TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalAug 18, 2025
comments(0)
5-min edit window · permanent after that